Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
Journal of Cellular and Molecular Medicine · 2024-01 · 28 (1)
DOI: 10.1111/jcmm.18044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.12.2023. Verfasst von Anqi Ge und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Ferroptosis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 290 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Natural Science Foundation of China, Scientific Research Fund of Hunan Provincial Education Department.
Abstract (Originalsprache)
Breast cancer is the most prevalent cancer worldwide and its incidence increases with age, posing a significant threat to women's health globally. Due to the clinical heterogeneity of breast cancer, the majority of patients develop drug resistance and metastasis following treatment. Ferroptosis, a form of programmed cell death dependent on iron, is characterized by the accumulation of lipid peroxides, elevated levels of iron ions and lipid peroxidation. The underlying mechanisms and signalling pathways associated with ferroptosis are intricate and interconnected, involving various proteins and enzymes such as the cystine/glutamate antiporter, glutathione peroxidase 4, ferroptosis inhibitor 1 and dihydroorotate dehydrogenase. Consequently, emerging research suggests that ferroptosis may offer a novel target for breast cancer treatment; however, the mechanisms of ferroptosis in breast cancer urgently require resolution. Additionally, certain natural compounds have been reported to induce ferroptosis, thereby interfering with breast cancer. Therefore, this review not only discusses the molecular mechanisms of multiple signalling pathways that mediate ferroptosis in breast cancer (including metastasis, invasion and proliferation) but also elaborates on the mechanisms by which natural compounds induce ferroptosis in breast cancer. Furthermore, this review summarizes potential compound types that may serve as ferroptosis inducers in future tumour cells, providing lead compounds for the development of ferroptosis‐inducing agents. Last, this review proposes the potential synergy of combining natural compounds with traditional breast cancer drugs in the treatment of breast cancer, thereby suggesting future directions and offering new insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
- People's Hospital of Ningxiang City, Ningxiang, China.
- Hunan University of Chinese Medicine, Changsha, China.
- Hunan University of Science and Technology, Xiangtan, China.
- The First People's Hospital Changde City, Changde, China.
ORCID-Profile: Qi He, Junpeng Chen
Förderung
- Hunan Provincial Natural Science Foundation of China
- Scientific Research Fund of Hunan Provincial Education Department
Zitieren
APA
Ge, A., He, Q., Zhao, D., Li, Y., Chen, J., Deng, Y., Xiang, W., Fan, H., Wu, S., Li, Y., Liu, L., & Wang, Y. (2024). Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. Journal of Cellular and Molecular Medicine, 28(1). https://doi.org/10.1111/jcmm.18044
Vancouver
Ge A, He Q, Zhao D, Li Y, Chen J, Deng Y, et al. Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. Journal of Cellular and Molecular Medicine. 2024;28(1). doi:10.1111/jcmm.18044
BibTeX
@article{Ge2024,
author = {Ge, Anqi and He, Qi and Zhao, Da and Li, Yuwei and Chen, Junpeng and Deng, Ying and Xiang, Wang and Fan, Hongqiao and Wu, Shiting and Li, Yan and Liu, Lifang and Wang, Yue},
title = {Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {1},
doi = {10.1111/jcmm.18044}
}
EUVIMED